1 1

NHD Distribution

Status BTA

Status BTA

Variation
$327.29 USD
$327.29 USD
Sale Sold out

Disclaimer:


Our point-of-care products can only be purchased by individuals or organizations with a valid CLIA certification, and first-time orders may experience shipping delays until certification verification is complete. We apologize for any inconvenience and appreciate your understanding in complying with regulatory guidelines

PROFESSIONAL USE ONLY - In order to complete the purchase of this item, a CLIA number and CLIA certification are required.

Contact us for special bulk order pricing on this product.

View full details
  • Description
  • Reviews

A rapid test for the qualitative detection of bladder tumor associated antigen in human urine.

The test is indicated for use as an aid in the management of bladder cancer patients in conjunction with cystoscopy. The simple urine sample collection also allows for improved patient comfort. Because tumor markers can be used to assess the response of a tumor treatment and for prognosis, rapid screening tests like the Status BTA product are very helpful in the treatment management of cancer patients.

 

Product Specifications

Tests/Box 25
Sample type Urine specimen collection
Time to results 5 minutes
Monitoring Sensitivity 67% / Specificity 70% 
Kit contents (25) test devices, (25) transfer pipettes, Package insert
Storage 35-86°F (2-30°C)
CLIA complexity Waived
Certification FDA


More Information